Meeting
2018 ASCO Annual Meeting
Phase III study of intraperitoneal/intravenous adjuvant chemotherapy compared intravenous adjuvant chemotherapy in patients with stage III gastric cancer.
Authors
Yang Yang
The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China
Yang Yang , Juan Du , Jia Wei , Wenxian Guan , Gang Chen , Meng Wang , Lixia Yu , Hanqing Qian , Yan Yang , Baorui Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
ChiCTR-IPR-15006202
Citation
J Clin Oncol 36, 2018 (suppl; abstr 4067)
DOI
10.1200/JCO.2018.36.15_suppl.4067
Abstract #
4067
Poster Bd #
256
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) in gastric cancer patients with stage III (POST trial).
First Author: Choong-kun Lee
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Post-recurrent survival of a phase III trial comparing adjuvant chemotherapy with docetaxel plus S-1 versus S-1 alone in stage III gastric cancer: A post-hoc analysis of the START-2 trial (JACCRO GC-07).
First Author: Hiroo Ishida
Poster
2019 ASCO Annual Meeting
POLEM: Avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III dMMR or POLE exonuclease domain mutant colon cancer—A phase III randomized study.
First Author: David Lau
Poster
2017 ASCO Annual Meeting
PRODIGE 34 ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer—A randomized phase III trial.
First Author: Thomas Aparicio